DRUGS giant GlaxoSmithKline has vigorously denied once again that
it tried to hide results or mislead regulators or the medical
community over paediatric clinical trial data for its antidepressant
Glaxo repeated that it is co-operating fully with the Medicines
and Healthcare products Regulatory Authority's ongoing investigation
which started this year.
The BBC's Panorama programme last night claimed that vital
information on the side effects of the drug have been lying dormant
in the MHRA files for at least 13 years.
The Panorama programme claimed that past trial results on the
drug contain evidence it may increase the risk of suicide in young
The programme also said that the trials had evidence that the
drug can leave a quarter of users addicted, while rapid increases in
its dosage can cause serious side effects.
Panorama alleged some of the evidence could have been spotted
earlier by the MHRA.
The MHRA denies the allegations while GlaxoSmithKline said the
drug's effectiveness had been demonstrated in clinical trials
involving more than 24,000 people.